Historic Shift in US Drug Policy: Cannabis Moved to Lower-Risk Category

This reclassification marks a pivotal turning point in federal drug policy, potentially unlocking vast opportunities for medical research and easing the financial hurdles for the industry. While federal illegality persists, the shift signals an unprecedented move toward reconciling federal law with state-level legalization trends.